Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.

Regenstrief Institute for Health Care and Indiana University, Indianapolis, Indiana 46202, USA.
Annals of internal medicine (Impact Factor: 16.1). 04/2007; 146(5):317-25.
Source: PubMed

ABSTRACT Anxiety, although as common as depression, has received less attention and is often undetected and undertreated.
To determine the current prevalence, impairment, and comorbidity of anxiety disorders in primary care and to evaluate a brief measure for detecting these disorders.
Criterion-standard study performed between November 2004 and June 2005.
15 U.S. primary care clinics.
965 randomly sampled patients from consecutive clinic patients who completed a self-report questionnaire and agreed to a follow-up telephone interview.
7-item anxiety measure (Generalized Anxiety Disorder [GAD]-7 scale) in the clinic, followed by a telephone-administered, structured psychiatric interview by a mental health professional who was blinded to the GAD-7 results. Functional status (Medical Outcomes Study Short Form-20), depressive and somatic symptoms, and self-reported disability days and physician visits were also assessed.
Of the 965 patients, 19.5% (95% CI, 17.0% to 22.1%) had at least 1 anxiety disorder, 8.6% (CI, 6.9% to 10.6%) had posttraumatic stress disorder, 7.6% (CI, 5.9% to 9.4%) had a generalized anxiety disorder, 6.8% (CI, 5.3% to 8.6%) had a panic disorder, and 6.2% (CI, 4.7% to 7.9%) had a social anxiety disorder. Each disorder was associated with substantial impairment that increased significantly (P < 0.001) as the number of anxiety disorders increased. Many patients (41%) with an anxiety disorder reported no current treatment. Receiver-operating characteristic curve analysis showed that both the GAD-7 scale and its 2 core items (GAD-2) performed well (area under the curve, 0.80 to 0.91) as screening tools for all 4 anxiety disorders.
The study included a nonrandom sample of selected primary care practices.
Anxiety disorders are prevalent, disabling, and often untreated in primary care. A 2-item screening test may enhance detection.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Re cei ved/Ge liş ta ri hi: 12.09.2011 Ac cep ted/Ka bul ta ri hi: 27.09.2011 © Arc hi ves of Neu ropsy chi atry, pub lis hed by Ga le nos Pub lis hing. / © Nö rop si ki yat ri Ar şi vi Der gi si, Ga le nos Ya yı ne vi ta ra f›n dan ba s›l m›fl t›r. ABS TRACT Objective: Our objective was to identify the validity, reliability and psychometric features of the Turkish adaptation of the Generalized Anxiety Disorder-7 (GAD-7) scale. Method: Patients who were diagnosed with 110 GAD patients and 112 healthy control subjects were included in this study. Three weeks after the initial administration, a certain group of the sample was administered the GAD-7 scale again. The principal components analysis for structural validity and confirmatory factor analysis were performed. Receiver operating characteristics (ROC) curve analysis was performed to identify the distinguishing feature. Positive predictive value, negative predictive value, positive and negative likelihood ratios were calculated at different cutoff levels. Results: The total scores for the GAD-7 scale-Turkish version in the GAD group were found to be statistically significantly higher than those in the control group. A significant correlation was observed between all items of the GAD-7 scale-Turkish version that was found to have good internal consistency and intermittent administration. In the factor analysis performed for assessing the construct validity, the factor structure of the GAD-7 scale-Turkish version was found to be similar to the original form and the construct validity was found to be good. Good compliance to single factor structure was observed in the confirmatory factor analysis. The most acceptable cutoff point of the GAD-7 scale-Turkish version was found to be 8.
  • Source
    Revue Européenne de Psychologie Appliquée 01/2015; 65(1):9-17. DOI:10.1016/j.erap.2014.10.001 · 0.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to verify whether tobacco use influenced treatment outcome in a population of treatment seeking individuals with gambling disorder. Gambling disorder is defined as persistent and maladaptive gambling behaviour which meets four or more outlined criteria in the DSM-5. Tobacco use is the most frequent comorbidity with gambling disorder. A total of 676 treatment seeking individuals with gambling disorder were assessed at the National Problem Gambling Clinic in London. We analysed differences in socio-demographic, clinical and gambling variables between smokers and non-smokers and the relation between smoking behaviour and treatment completion and outcome. 46.4 % (314) of our sample were daily tobacco users and were significantly younger, less likely to be in a stable relationship, more likely to be unemployed and have a lower education level. They were also significantly more likely to score higher on the AUDIT-C score and were significantly more likely to have used drugs in the last 30 days. There was no significant difference in PGSI score between smokers and non-smokers. We found that tobacco smokers did not have higher PGSI scores than non-smokers. Moreover, there was no significant difference between tobacco users and nonusers in terms of treatment completion and treatment outcome.
    Journal of Gambling Studies 03/2015; DOI:10.1007/s10899-015-9533-2 · 1.47 Impact Factor


Available from
May 23, 2014